Tag: Biologics|Diabetes|Non-Medical Switching|Oncology|Regulatory Issues

Health Plan’s Cost Cutting Fuels Non-Medical Switching Worries

Biosimilar medications designed to give patients more options may instead become health plans’ newest tool for limiting patient access.